Psychoactive Drug Diversion
Author : United States. Congress. House. Select Committee on Narcotics Abuse and Control
Publisher :
Page : 20 pages
File Size : 11,67 MB
Release : 1981
Category : Drugs
ISBN :
Author : United States. Congress. House. Select Committee on Narcotics Abuse and Control
Publisher :
Page : 20 pages
File Size : 11,67 MB
Release : 1981
Category : Drugs
ISBN :
Author : United States. Congress. House. Select Committee on Narcotics Abuse and Control
Publisher :
Page : 14 pages
File Size : 49,26 MB
Release : 1981
Category : Drugs
ISBN :
Author : United States. Congress. House. Committee on the Judiciary. Subcommittee on Crime
Publisher :
Page : 474 pages
File Size : 12,45 MB
Release : 1985
Category : Drugs
ISBN :
Author :
Publisher :
Page : 368 pages
File Size : 40,12 MB
Release : 1976
Category : Drug abuse
ISBN :
Author :
Publisher :
Page : 356 pages
File Size : 18,9 MB
Release : 1993
Category : Drug traffic
ISBN :
Author : World Health Organization. Department of Mental Health and Substance Abuse
Publisher : World Health Organization
Page : 133 pages
File Size : 19,13 MB
Release : 2009
Category : Medical
ISBN : 9241547545
"These guidelines were produced by the World Health Organization (WHO), Department of Mental Health and Substance Abuse, in collaboration with the United Nations Office on Drugs and Crime (UNODC) a Guidelines Development Group of technical experts, and in consultation with the International Narcotics Control Board (INCB) secretariat and other WHO departments. WHO also wishes to acknowledge the financial contribution of UNODC and the Joint United Nations Programme on HIV/AIDS (UNAIDS) to this project. " - p. iv
Author : National Academies of Sciences, Engineering, and Medicine
Publisher : National Academies Press
Page : 483 pages
File Size : 42,7 MB
Release : 2017-09-28
Category : Medical
ISBN : 0309459575
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Author : United States. Drug Enforcement Administration. Office of Diversion Control
Publisher :
Page : 20 pages
File Size : 50,59 MB
Release : 1992
Category : Drug control
ISBN :
Author : Owen Bowden-Jones
Publisher : Cambridge University Press
Page : 141 pages
File Size : 35,69 MB
Release : 2020-10-08
Category : Medical
ISBN : 1911623095
Emerging illicit drugs pose a significant clinical challenge. This handbook offers an engaging, concise guide to managing these challenges.
Author : Katherine Eban
Publisher : Houghton Mifflin Harcourt
Page : 479 pages
File Size : 19,2 MB
Release : 2006-04-18
Category : Medical
ISBN : 9780156030854
An exploration of drug counterfeiting activities in America traces a drug theft investigation in Florida with ties to a national network of drug polluters and the government, exposing how political interests may be compromising the integrity of the nation's medical distribution system. Reprint. 30,000 first printing.